Middle-aged adults with comorbid insomnia and sleep apnea faced significantly elevated odds for uncontrolled hypertension vs. adults without these conditions, according to results published in Annals ...

Sleep Cycle, the world's leading AI-powered sleep technology company, today announced that the company has signed a start-up agreement with a leading US-based clinical research organization (CRO) to c ...

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As respiratory health challenges increase globally ...

Diabetes care is undergoing a major transformation driven by GLP-1 receptor agonists, which have expanded beyond glycemic ...

DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- Careboo, an innovator in therapeutic technology and ...

A mother feared she was developing dementia before television presenter Davina McCall helped her discover the true cause of ...

AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.

Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look ...

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Finding the right balance between safety and ...

Garmin has announced the Tactix 8 Cerakote Edition, a new variant of its high-end tactical smartwatch that builds on last ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.